Last quarter (Q4 2022), Anatara Lifesciences Ltd's total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Anatara Lifesciences Ltd's net income was AU$―. See Anatara Lifesciences Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	-	-	-	AU$ 663.40K
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	AU$ 663.40K
Operating Expense	-	AU$ 3.02M	AU$ 3.11M	AU$ 4.21M	AU$ 4.48M
Operating Income	-	AU$ -3.02M	AU$ -3.11M	AU$ -4.21M	AU$ -3.82M
Net Non Operating Interest Income Expense	-	AU$ 2.69K	AU$ 8.82K	AU$ 52.06K	AU$ 142.50K
Other Income Expense	-	AU$ 487.24K	AU$ 1.11M	AU$ 789.21K	AU$ 807.97K
Pretax Income	-	AU$ -2.53M	AU$ -2.00M	AU$ -3.36M	AU$ -2.87M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -2.53M	AU$ -2.00M	AU$ -3.36M	AU$ -2.87M
Basic EPS	-	AU$ -0.03	AU$ -0.03	AU$ -0.07	AU$ -0.06
Diluted EPS	-	AU$ -0.03	AU$ -0.03	AU$ -0.07	AU$ -0.06
Basic Average Shares	-	AU$ 73.43M	AU$ 62.71M	AU$ 49.67M	AU$ 49.41M
Diluted Average Shares	-	AU$ 73.43M	AU$ 62.71M	AU$ 49.67M	AU$ 49.41M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -2.53M	AU$ -2.00M	AU$ -3.36M	AU$ -2.87M
Normalized Income	-	AU$ -2.53M	AU$ -2.00M	AU$ -3.36M	AU$ -2.87M
Interest Expense	-	AU$ 3.32K	AU$ 300.00	-	-
EBIT	-	AU$ -2.53M	AU$ -2.00M	AU$ -4.21M	AU$ -3.82M
EBITDA	-	AU$ -2.50M	AU$ -1.99M	AU$ -4.19M	AU$ -3.80M

Currency in AUD

Anatara Lifesciences Ltd Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing